| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |